Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.
作者信息
Weber Michael, Hamm Christian
机构信息
Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany.
出版信息
Heart. 2006 Jun;92(6):843-9. doi: 10.1136/hrt.2005.071233.
Abstract
摘要
相似文献
1
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.
Heart. 2006 Jun;92(6):843-9. doi: 10.1136/hrt.2005.071233.
2
Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Clin Chim Acta. 2019 Apr;491:8-14. doi: 10.1016/j.cca.2018.12.025. Epub 2018 Dec 28.
3
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27.
4
The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
Expert Rev Cardiovasc Ther. 2015;13(9):1017-30. doi: 10.1586/14779072.2015.1071664. Epub 2015 Jul 21.
5
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
6
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
J Am Heart Assoc. 2017 May 29;6(6):e004743. doi: 10.1161/JAHA.116.004743.
7
Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
Circ J. 2007 Dec;71(12):1873-8. doi: 10.1253/circj.71.1873.
8
Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
Crit Pathw Cardiol. 2009 Dec;8(4):146-50. doi: 10.1097/HPC.0b013e3181c4a0c6.
9
High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
Clin Chem. 2004 Nov;50(11):2052-8. doi: 10.1373/clinchem.2004.038752. Epub 2004 Sep 2.
10
Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
Clin Chem. 2009 Jan;55(1):78-84. doi: 10.1373/clinchem.2008.108928. Epub 2008 Nov 21.
引用本文的文献
1
Accuracy of NT-proBNP for predicting mortality amongst patients with ischemic stroke: a systematic review and meta-analysis.
BMC Med. 2025 Aug 15;23(1):476. doi: 10.1186/s12916-025-04299-1.
2
Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure: a prospective cohort study in Vietnam.
BMC Cardiovasc Disord. 2025 Jul 18;25(1):523. doi: 10.1186/s12872-025-04994-0.
3
The Role of Cardiac Biomarkers in Evaluating Takotsubo Cardiomyopathy: A Systematic Review.
Cureus. 2025 Jun 16;17(6):e86168. doi: 10.7759/cureus.86168. eCollection 2025 Jun.
4
Utilizing natriuretic peptides for predicting heart failure risk following myocardial infarction.
Cardiovasc Endocrinol Metab. 2025 Jul 15;14(3):e00338. doi: 10.1097/XCE.0000000000000338. eCollection 2025 Sep.
5
Comparative analysis of plasma BNP and NT-proBNP levels, and NT-proBNP/BNP ratio in patients with chronic kidney disease.
Hypertens Res. 2025 Jul 1. doi: 10.1038/s41440-025-02272-2.
6
Assessment of cardiac biomarker "point-of-care" testing as postmortem diagnostic tool.
Int J Legal Med. 2025 May 29. doi: 10.1007/s00414-025-03517-y.
7
Nonclinical Safety Evaluation of 2-Deoxy-D-Glucose Following Twice-Daily Oral Administration for 28 Days in Beagle Dogs.
Int J Toxicol. 2025 Sep-Oct;44(5):407-414. doi: 10.1177/10915818251340393. Epub 2025 May 26.
8
Monitoring the Effects of Cardiac Rehabilitation Programs in Heart Failure Patients: The Role of Biomarkers.
High Blood Press Cardiovasc Prev. 2025 May;32(3):287-297. doi: 10.1007/s40292-025-00707-y. Epub 2025 May 6.
9
Obesity-Related Phenotype of Heart Failure With Preserved Ejection Fraction: A Comprehensive Review.
Cureus. 2025 Mar 31;17(3):e81512. doi: 10.7759/cureus.81512. eCollection 2025 Mar.
10
Association between the preoperative N-terminal pro-B-type natriuretic peptide and acute kidney injury in gastrointestinal surgery patients managed with enhanced recovery strategy: a retrospective cohort study.
Perioper Med (Lond). 2025 Apr 22;14(1):45. doi: 10.1186/s13741-025-00528-6.
本文引用的文献
1
NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation.
J Card Fail. 2005 Jun;11(5 Suppl):S38-41. doi: 10.1016/j.cardfail.2005.04.012.
2
Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Hypertension. 2005 Jul;46(1):118-23. doi: 10.1161/01.HYP.0000170140.36633.8f. Epub 2005 Jun 6.
3
Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
Heart. 2005 May;91(5):606-12. doi: 10.1136/hrt.2004.037762.
4
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
Am J Cardiol. 2005 Apr 15;95(8):948-54. doi: 10.1016/j.amjcard.2004.12.032.
5
Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
Eur Heart J. 2005 May;26(10):1023-30. doi: 10.1093/eurheartj/ehi236. Epub 2005 Mar 21.
6
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
N Engl J Med. 2005 Feb 17;352(7):666-75. doi: 10.1056/NEJMoa042330.
7
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Circulation. 2004 Nov 16;110(20):3206-12. doi: 10.1161/01.CIR.0000147611.92021.2B. Epub 2004 Nov 8.
8
N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
Am Heart J. 2004 Oct;148(4):612-20. doi: 10.1016/j.ahj.2004.04.021.
9
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Circulation. 2004 Sep 28;110(13):1780-6. doi: 10.1161/01.CIR.0000143059.68996.A7. Epub 2004 Sep 20.
10
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
Circulation. 2004 May 18;109(19):2302-8. doi: 10.1161/01.CIR.0000126825.50903.18. Epub 2004 Apr 26.
Zotero 插件